5′ N |
5′ nucleotidase |
AD |
Alzheimer’s disease |
AMD |
Age-related macular degeneration |
AT1-R |
Angiotensin II type-1 receptor |
β-AR |
β-adrenergic receptor |
BRB |
Blood-retinal barrier |
COX |
Cyclooxygenase |
DHA |
Docosahexaenoic |
DR |
Diabetic retinopathy |
EPA |
Eicosapentaenoic |
eEPC |
Early endothelial progenitor cells |
Epo |
Erythropoietin |
FDA |
Food and Drug Administration |
G-CSF |
Granulocyte colony-stimulating factor |
HIF |
Hypoxia-inducible factor |
HRE |
Hypoxia response element |
HSPG |
Heparin sulphate proteoglycans |
IGF-1 |
Insulin-like growth factor-1 |
KDR |
Kinase insert domain-containing receptor |
KLT-1 |
Kms-related tyrosine kinase 1 |
mTOR |
Mammalian target of rapamycin |
NOS |
Nitric oxide synthetase |
NRP |
Neurophilin |
ω-3 PUFAs |
Omega-3 long-chain polyunsaturated fatty acids |
OIR |
Oxygen-induced retinopathy |
OPC |
Outgrowth endothelial cells |
PD |
Parkinson’s disease |
PHD |
Prolyl hydroxylase |
RAS |
Renin-angiotensin system |
RGC |
Retinal ganglion cells |
ROP |
Retinopathy of prematurity |
ROS |
Reactive oxygen species |
SC |
Stem cell |
SRPK1 |
Serine arginine protein kinase 1 |
SRSF1 |
Serine-rich splicing factor-1 |
STOP-ROP |
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity |
VEGF |
Vascular endothelial growth factor |